Humanoid Robots: Figure, Optimus, Unitree, 1X, Agility — 2026-10-27
Tesla has officially commenced production of its Optimus humanoid robots at the Fremont factory, targeting a massive ramp-up to 20,000 units per week by late 2027, despite a 43% drop in quarterly profits. Meanwhile, Chinese leader Unitree is leveraging stock market momentum to fund "self-evolving" AI capabilities, while Japanese giants Toyota and Kawasaki are accelerating their own humanoid strategies through new partnerships and capital investments.
Humanoid Robots: Figure, Optimus, Unitree, 1X, Agility — 2026-10-27
Top developments
Tesla Optimus enters production at Fremont
Tesla has begun manufacturing its Optimus humanoid robots on a dedicated high-volume line in Fremont, California. CEO Elon Musk stated during the Q3 earnings call that the company aims to reach a production rate of 20,000 robots per week by the end of 2027, with customer deliveries expected to begin in late 2027. This move comes as Tesla reported a 43% drop in quarterly net income, driven by increased capital spending on robotics and AI infrastructure.
Unitree’s "self-evolving" AI and market surge
Unitree Robotics, the Chinese humanoid leader, is developing an AI system designed to allow its robots to "self-improve" and evolve without constant human retraining, a move analysts describe as a potential threat to Tesla’s approach. This announcement coincides with a dramatic stock market reaction: Unitree’s shares surged over 65% in seven trading days, pushing its market capitalization back above 270 billion yuan (approx. $38 billion). The company’s H2-X model recently demonstrated advanced physical capabilities, including jumping over cars and blocking blades, in a viral video showcasing its agility and balance.
Toyota and Kawasaki accelerate Japanese humanoid race
At the 2026 Japan Mobility Show on October 26, Toyota unveiled significant strides in factory automation featuring its humanoid robots, signaling a serious commitment to integrating humanoids into manufacturing workflows. Concurrently, Kawasaki Heavy Industries announced a strategic pivot to become an "AI Robotics Heavy Industries" company, setting aside approximately 550 billion yen for growth investments between 2027 and 2030 to develop domestic AI humanoids.
Local view
China: Valuation concerns vs. hype Chinese financial media is closely watching Unitree’s stock volatility. 21st Century Business Herald notes that while the stock rebounded 65%, the company issued an urgent post-market warning that humanoid robots are still in the "early stages of commercialization," cautioning investors against overheated expectations. Meanwhile, Sina Finance highlights that investors are becoming skeptical of "demo-only" companies, demanding actual revenue and deployment metrics from competitors like Agibot (Zhiyuan), whose IPO progress has slowed due to these stricter capital standards.
Japan: Strategic repositioning Japanese outlets like Nikkei report that Kawasaki’s President is emphasizing the need to accelerate development of domestic "Physical AI," even collaborating with competitors to catch up to global leaders. The narrative in Japan is shifting from simple R&D to a national industrial strategy, with Toyota’s showcase at the Mobility Show being framed as a critical step in maintaining Japan’s manufacturing sovereignty.
Context & numbers
- Tesla Production Targets: Tesla aims for 20,000 Optimus robots per week by end of 2027.
- Unitree Stock Performance: Up 65.89% over 7 trading days as of Oct 26, with a market cap of 271.8 billion yuan.
- Kawasaki Investment: 550 billion yen allocated for AI robotics growth from 2027–2030.
- Tesla Financials: Q3 net income fell 43% as capital expenditures more than doubled to support the Optimus ramp-up.
On the radar
- Tesla Hand Durability Issues: Musk admitted on the earnings call that "hands" remain a significant technical hurdle for Optimus, delaying full utility.
- 1X NEO Deliveries: 1X is still on track to deliver its first NEO consumer home robots by the end of 2026.
- Agibot IPO Status: The IPO for Agibot (Zhiyuan) remains pending, with analysts suggesting the delay is linked to the need to prove commercial viability beyond prototype demos.
This content was collected, curated, and summarized entirely by AI — including how and what to gather. It may contain inaccuracies. Crew does not guarantee the accuracy of any information presented here. Always verify facts on your own before acting on them. Crew assumes no legal liability for any consequences arising from reliance on this content.
Powered by
